Drug Shortage Report for LEVOFLOXACIN IN 5% DEXTROSE INJECTION

Last updated on 2025-02-07 History
Report ID 236630
Drug Identification Number 02314932
Brand name LEVOFLOXACIN IN 5% DEXTROSE INJECTION
Common or Proper name LEVOFLOXACIN IN 5% DEXTROSE INJECTION
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) LEVOFLOXACIN
Strength(s) 5MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 24 X 100ML
ATC code J01MA
ATC description QUINOLONE ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-10-15
Estimated end date
Actual end date 2025-02-06
Shortage status Resolved
Updated date 2025-02-07
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: [email protected]

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v14 2025-02-07 French Compare
v13 2025-02-07 English Compare
v12 2025-01-31 French Compare
v11 2025-01-31 English Compare
v10 2025-01-17 French Compare
v9 2025-01-17 English Compare
v8 2024-11-04 French Compare
v7 2024-11-04 English Compare
v6 2024-10-16 English Compare
v5 2024-10-15 French Compare
v4 2024-10-15 English Compare
v3 2024-10-02 English Compare
v2 2024-09-04 French Compare
v1 2024-09-04 English Compare

Showing 1 to 14 of 14